Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

NCT04943627 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Strategic Business Decision

Conditions

Advanced Cancer
Metastatic Cervical Cancer

Interventions

DRUG: Balstilimab (BAL)
DRUG: Topotecan
DRUG: Vinorelbine
DRUG: Gemcitabine
DRUG: Irinotecan
DRUG: Pemetrexed

Sponsor

Agenus Inc.

Collaborators

[object Object]